Covered recipient · General Payments record
MARVIN I RUDERMAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2025
$18,523.16
- Reported across 465 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,170.62 | 31 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ARGENX US, INC. | $270.98 | 4 |
| Alexion Pharmaceuticals, Inc. | $141.89 | 2 |
| MicroTransponder, Inc. | $138.97 | 1 |
| Lilly USA, LLC | $134.82 | 2 |
| Amgen Inc. | $121.35 | 2 |
| ABBVIE INC. | $94.96 | 6 |
| Genentech USA, Inc. | $77.48 | 4 |
| CSL Behring | $44.95 | 2 |
| Ultragenyx Pharmaceutical Inc. | $24.35 | 1 |
| Biogen, Inc. | $20.33 | 1 |
| Celgene Corporation | $18.98 | 1 |
| PFIZER INC. | $18.46 | 1 |
| UCB, Inc. | $18.17 | 1 |
| Neurocrine BioSciences, Inc. | $15.87 | 1 |
| Acerta Pharma LLC | $15.18 | 1 |
| GE HEALTHCARE | $13.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.92 | 01/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203964086 | CMS |
| ABBVIE INC. | $14.93 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203964092 | CMS |
| ABBVIE INC. | $14.16 | 05/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203964098 | CMS |
| ABBVIE INC. | $16.92 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203964103 | CMS |
| ABBVIE INC. | $14.04 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203964109 | CMS |
| ABBVIE INC. | $17.99 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203964115 | CMS |
| Alexion Pharmaceuticals, Inc. | $17.85 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202961470 | CMS |
| Alexion Pharmaceuticals, Inc. | $124.04 | 07/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202922616 | CMS |
| Amgen Inc. | $18.85 | 04/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228522260 | CMS |
| Amgen Inc. | $102.50 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228522258 | CMS |
| ARGENX US, INC. | $116.50 | 01/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240423552 | CMS |
| ARGENX US, INC. | $125.00 | 04/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240432166 | CMS |
| ARGENX US, INC. | $14.94 | 06/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240430712 | CMS |
| ARGENX US, INC. | $14.54 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240458591 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.18 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206391090 | CMS |
| Biogen, Inc. | $20.33 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208304580 | CMS |
| Celgene Corporation | $18.98 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184827845 | CMS |
| CSL Behring | $24.33 | 04/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232382680 | CMS |
| CSL Behring | $20.62 | 10/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232382696 | CMS |
| GE HEALTHCARE | $13.88 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244289470 | CMS |
| Genentech USA, Inc. | $18.50 | 07/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211544780 | CMS |
| Genentech USA, Inc. | $19.98 | 10/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211544783 | CMS |
| Genentech USA, Inc. | $19.02 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211544788 | CMS |
| Genentech USA, Inc. | $19.98 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211544794 | CMS |
| Lilly USA, LLC | $17.34 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186821472 | CMS |
| Lilly USA, LLC | $117.48 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186781111 | CMS |
| MicroTransponder, Inc. | $138.97 | 12/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220109582 | CMS |
| Neurocrine BioSciences, Inc. | $15.87 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243040569 | CMS |
| PFIZER INC. | $18.46 | 05/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231532957 | CMS |
| UCB, Inc. | $18.17 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224378028 | CMS |
| Ultragenyx Pharmaceutical Inc. | $24.35 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1253155421 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.